Patrys Limited (PAB.AX)
Develops antibody treatments targeting cancer and inflammatory diseases caused by immune cell dysfunction.
0.04-0.02%
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+11.4%
The outlook
Patrys Limited trades at $0.039, positioned roughly midway in its 52-week range with mixed momentum against moving averages. Analyst coverage shows a notably bullish lean, with the average price target sitting around 233% above the current price, though this reflects the stock's penny-stock nature and wide valuation spreads. The overall sentiment leans bullish, though the mixed technical picture suggests caution.
What’s behind the score
Price trendMixed vs its moving averages
52-week range52% of the way from its 52-week low to high
Price targetAvg target +233% vs current price
Market cap
$13.7M
52-wk high
0.05
52-wk low
0.03
50-day avg
0.04
200-day avg
0.03
Trailing P/E
—